SomaLogic, Inc. (NASDAQ:SLGCW) Short Interest Down 19.7% in January
SomaLogic, Inc. (NASDAQ:SLGCW) Short Interest Down 19.7% in January
SomaLogic, Inc operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.SomaLogic, Inc. (NASDAQ:SLGCW – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 20,800 shares, a drop of 19.7% from the January 15th total of 25,900 shares. Based on an average daily volume of 11,300 shares, the days-to-cover ratio is presently 1.8 days.
SomaloGic, Inc.（纳斯达克股票代码：SLGCW — Get Rating）是1月份空头利率大幅下降的受益者。截至1月31日，空头利率共计20,800股，较1月15日的25,900股总额下降了19.7％。根据11,300股的平均每日成交量，目前的天数与覆盖率为1.8天。
Institutional Trading of SomaLogic
SomaloGic 的机构交易
A number of hedge funds have recently made changes to their positions in the business. Saba Capital Management L.P. acquired a new stake in shares of SomaLogic in the third quarter valued at approximately $43,000. LMR Partners LLP lifted its position in shares of SomaLogic by 64.0% in the third quarter. LMR Partners LLP now owns 573,577 shares of the company's stock valued at $1,663,000 after buying an additional 223,842 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its position in shares of SomaLogic by 4.1% in the third quarter. Point72 Asset Management L.P. now owns 1,267,427 shares of the company's stock valued at $556,000 after buying an additional 50,000 shares during the last quarter.
许多对冲基金最近调整了其在该业务中的头寸。Saba Capital Management L.P. 在第三季度收购了SomaloGic股票的新股份，价值约为43,000美元。LMR Partners LLP在第三季度将其在SomaloGic的股票头寸提高了64.0％。LMR Partners LLP在上个季度又购买了223,842股股票后，现在拥有该公司573,577股股票，价值166.3万美元。最后，Point72 Asset Management L.P. 在第三季度将其在SomaloGic股票中的头寸提高了4.1％。Point72 Asset Management L.P. 在上个季度又购买了5万股股票后，现在拥有该公司1,267,427股股票，价值55.6万美元。
SomaLogic Stock Down 5.4 %
SomaloGic 股价下跌 5.4 ％
SLGCW stock opened at $0.44 on Monday. The company has a 50 day moving average of $0.47. SomaLogic has a twelve month low of $0.27 and a twelve month high of $3.44.
周一，SLGCW股票开盘价为0.44美元。该公司的50天移动平均线为0.47美元。SomaloGic创下十二个月低点0.27美元，十二个月高点3.44美元。
SomaLogic Company Profile
SomaloGic 公司简介
SomaLogic, Inc operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.
SomaloGic, Inc是一家在美国的蛋白质生物标志物发现和临床诊断公司。它开发慢速率改性适配体（SomaMers），即改性核酸基蛋白结合试剂，对其同源蛋白具有特异性；并提供专有的 SomaScan 服务，提供多重蛋白质检测和复杂生物样本中蛋白质水平的量化。
Read More
阅读更多
- Get a free copy of the StockNews.com research report on SomaLogic (SLGCW)
- MarketBeat Week in Review – 2/6 – 2/10
- Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
- The Bottom Is In For Cloudflare Stock
- 3 Tickers Leading a Meme Stock Revival
- Microsoft-Activision Blizzard Merger: Navigating Risk and Reward
- 免费获取 StockNews.com 关于 SomaloGic（SLGCW）的研究报告的副本
- MarketBeat 一周回顾 — 2/6 — 2/10
- Snowflake 会玩艰难的雪橇，想保持拉力赛活力吗？
- Cloudflare 股票已触底
- 引领模因股票复苏的 3 只股票
- 微软-动视暴雪合并：驾驭风险与回报
Receive News & Ratings for SomaLogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SomaLogic and related companies with MarketBeat.com's FREE daily email newsletter.
接收 SomaloGic Daily 的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Somalogic及相关公司的最新新闻和分析师评级的简明每日摘要。
